Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer

Erstveröffentlichung
2017Authors
Schramm, Amelie
Schochter, Fabienne
Friedl, Thomas W. P.
de Greqorio, Nikolaus
Andergassen, Ulrich
Wissenschaftlicher Artikel
Published in
Clinical Breast Cancer ; 17 (2017), 4. - S. 279-285. - ISSN 1526-8209. - eISSN 1938-0666
Link to publication
https://dx.doi.org/10.1016/j.clbc.2016.11.008Institutions
UKU. Klinik für Frauenheilkunde und GeburtshilfeSubject headings
[Free subject headings]: Adjuvant chemotherapy | Anthracyclines | Circulating tumor cells | HER2-negative early breast cancer | randomized-trial | premenopausal women | pooled analysis | her2 status | cyclophosphamide | fluorouracil | methotrexate | epirubicin | relevance | predicts[DDC subject group]: DDC 610 / Medicine & health